Assessment of Capecitabine and Bevacizumab with or Without Atezolizumab for the Treatment of Refractory Metastatic Colorectal Cancer: A Randomized Clinical Trial
Niharika B. Mettu, Fang Shu Ou, Tyler J. Zemla, Thorvardur R. Halfdanarson, Heinz Josef Lenz, Rimini A. Breakstone, Patrick M. Boland, Oxana V. Crysler, Christina Wu, Andrew B. Nixon, Emily Bolch, Donna Niedzwiecki, Alicia Elsing, Herbert I. Hurwitz, Marwan G. Fakih, Tanios Bekaii-Saab
Research output: Contribution to journal › Article › peer-review
Fingerprint
Dive into the research topics of 'Assessment of Capecitabine and Bevacizumab with or Without Atezolizumab for the Treatment of Refractory Metastatic Colorectal Cancer: A Randomized Clinical Trial'. Together they form a unique fingerprint.